Skip to content
Search

Latest Stories

Community pharmacies in Northern Ireland offer Moderna Covid-19 vaccines

Northern Ireland has initiated the rollout of the Moderna Covid-19 vaccine through 16 selected community pharmacies to boost vaccine uptake. 

Health Minister Robin Swann has welcomed an expansion of the community pharmacy Covid-19 vaccination service with the phased deployment of the Moderna vaccine.


The vaccine will be available to eligible individuals aged 18 years and over.

The roll out builds on the success of the existing Covid-19 vaccination service, which has now delivered over 115,000 doses of the AstraZeneca vaccine from almost 350 community pharmacies across Northern Ireland.

The new service will initially offer the Moderna vaccine from 16 pharmacies with more pharmacies being added to the service on a rolling basis over the coming weeks.

Locations have been identified and selected based on vaccine uptake data to help reach as many people as possible in areas of lower uptake and to make it easier than ever for people to get their vaccine and protect themselves and their loved ones.

Minister Swann said: “While the logistical challenges with deployment of the Moderna vaccine are considerable, the number of participating pharmacies offering Moderna will continue to increase over the coming weeks and this will help many more people to come forward to access their vaccine in an easy and convenient location for them.”

Cathy Harrison, Chief Pharmaceutical Officer said: “Pharmacy teams across Northern Ireland should be very proud of the contribution they have made to the success of the Covid-19 vaccination programme. Their actions have undoubtedly saved lives.

“The deployment of the Moderna vaccine from an increasing number of community pharmacies over the coming weeks will play a vital part in our continued fight back against the virus.”

Joe Brogan, Head of Pharmacy and Medicines Management at the Health and Social Care Board said: “Community pharmacies are extremely accessible healthcare venues which have successfully demonstrated the delivery of flu vaccines and more recently Covid-19 vaccination.

“Rolling the Moderna vaccine out through selected pharmacies will, I hope, provide the opportunity for even greater uptake of these lifesaving vaccines.”

Gerard Green, Chief Executive of Community Pharmacy Northern Ireland said: “We welcome the inclusion of Moderna to the Covid-19 vaccination programme, particularly for those in the under 40s age group. Community pharmacy is embedded in the heart of local communities, and this has been important in the vaccine roll out to date, providing patients with the option to receive their vaccine from a convenient and familiar health care professional, that they know and trust.

“As the Moderna vaccine is initially being rolled out to a limited number of pharmacies, I would ask the public to please be patient with community pharmacy teams as we continue to deliver pharmacy services and play our part in helping to protect the local population through the Covid-19 vaccination programme.”

The Minister added: “Cases have continued to rise over recent weeks and we are now also beginning to see the pressures mounting on our hospitals, with increasing demand for intensive care beds – albeit at a lower rate, thanks to the effectiveness of our vaccination programme. If we can make a concerted effort to increase vaccine uptake in the next week or so, this can help make a decisive difference, in terms of preventing serious illness and hospitalisations.

“If you haven’t yet received your first dose of the vaccine – don’t delay, act today.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less